Viral Resistance in Hepatitis C Virus Genotype 1-Infected Patients Receiving the NS3 Protease Inhibitor Faldaprevir (BI 201335) in a Phase 1b Multiple-Rising-Dose Study
Supplemental material
Files in this Data Supplement:
Supplemental file 1
-
Supplemental Figures S1 to S3.
PDF, 941K